These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6252336)

  • 1. Activation of mouse lymphocytes by vesicular stomatitis virus.
    Goodman-Snitkoff GW; McSharry JJ
    J Virol; 1980 Sep; 35(3):757-65. PubMed ID: 6252336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
    Bachmann MF; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1995 Dec; 25(12):3445-51. PubMed ID: 8566036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution with T lymphocytes protects nude mice from a central nervous system disorder induced by a temperature-sensitive vesicular stomatitis virus.
    Doll SC; Johnson TC
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1969-77. PubMed ID: 2841409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The production of vesicular stomatitis virus by antigen- or mitogen-stimulated lymphocytes and continuous lymphoblastoid lines.
    Nowakowski M; Feldman JD; Kano S; Bloom BR
    J Exp Med; 1973 Apr; 137(4):1042-59. PubMed ID: 4348276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of delayed-type hypersensitivity by vesicular stomatitis virus infection in mice.
    Katsura Y; Takaoki M; Kono Y; Minato N
    J Immunol; 1980 Oct; 125(4):1459-62. PubMed ID: 6157735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of a vesicular stomatitis virus infection in primary lymphocytes is restricted at multiple levels during B cell activation.
    Schmidt MR; Gravel KA; Woodland RT
    J Immunol; 1995 Sep; 155(5):2533-44. PubMed ID: 7650383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenic activity of Sindbis virus and its isolated glycoproteins.
    Goodman-Snitkoff G; McSharry JJ
    Infect Immun; 1982 Dec; 38(3):1242-8. PubMed ID: 6984018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus.
    Burkhart C; Freer G; Castro R; Adorini L; Wiesmüller KH; Zinkernagel RM; Hengartner H
    J Virol; 1994 Mar; 68(3):1573-80. PubMed ID: 7508998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular stomatitis virus Indiana glycoprotein as a T-cell-dependent and -independent antigen.
    Freer G; Burkhart C; Ciernik I; Bachmann MF; Hengartner H; Zinkernagel RM
    J Virol; 1994 Jun; 68(6):3650-5. PubMed ID: 7910641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formalin inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses.
    Bachmann MF; Kündig TM; Kalberer CP; Hengartner H; Zinkernagel RM
    J Virol; 1993 Jul; 67(7):3917-22. PubMed ID: 8389912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.
    Forman J; Goodenow RS; Hood L; Ciavarra R
    J Exp Med; 1983 Apr; 157(4):1261-72. PubMed ID: 6187888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.
    Bowman MR; Lyles DS; Parce JW
    J Virol; 1987 Jun; 61(6):1992-8. PubMed ID: 3033326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes.
    Goodman-Snitkoff G; Mannino RJ; McSharry JJ
    J Exp Med; 1981 Jun; 153(6):1489-502. PubMed ID: 6265586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal.
    Fehr T; Bachmann MF; Bluethmann H; Kikutani H; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Mar; 168(2):184-92. PubMed ID: 8640864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed appearance of pseudotypes between vesicular stomatitis virus influenza virus during mixed infection of MDCK cells.
    Roth MG; Compans RW
    J Virol; 1981 Dec; 40(3):848-60. PubMed ID: 6275120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.
    Huneycutt BS; Bi Z; Aoki CJ; Reiss CS
    J Virol; 1993 Nov; 67(11):6698-706. PubMed ID: 8105106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of vesicular stomatitis virus in athymic nude mice: mutations associated with natural killer cell selection.
    Vandepol SB; Holland JJ
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():441-51. PubMed ID: 3005478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.
    Roscoe DM; Ishikawa K; Lyles DS
    J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk.
    Rosenthal KL; Zinkernagel RM
    J Immunol; 1981 Feb; 126(2):446-51. PubMed ID: 6256440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.